QUINCY − Mayor Thomas Koch wants the city to borrow $157 million to build two public parking garages in a section of Quincy Center known as the Ross Lot. The garages would be incorporated into ...
The CellFX nsPFA percutaneous electrode system. [Image courtesy of Pulse Biosciences] Pulse Biosciences (Nasdaq:PLSE) announced that its board of directors approved plans to initiate a rights ...
HAYWARD, Calif. - Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company, has announced a rights offering for its common stockholders, aiming to raise up to $60 million. The ...
HAYWARD, Calif. - Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company, has announced a rights offering for its common stockholders, aiming to raise up to $60 million. The ...
HAYWARD, Calif. - Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company, has announced a rights offering for its common stockholders, aiming to raise up to $60 million. The ...
HAYWARD, Calif. - Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company, has announced a rights offering for its common stockholders, aiming to raise up to $60 million. The ...
HAYWARD, Calif. - Pulse Biosciences, Inc. (NASDAQ: NASDAQ: PLSE ), a bioelectric medicine company, has announced a rights offering for its common stockholders, aiming to raise up to $60 million. The ...
HAYWARD, Calif. - Pulse Biosciences, Inc. (NASDAQ : NASDAQ: PLSE ), a bioelectric medicine company, has announced a rights offering for its common stockholders, aiming to raise up to $60 million. The ...
Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company, has announced a rights offering for its common stockholders, aiming to raise up to $60 million. The offering will ...
Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company, has announced a rights offering for its common stockholders, aiming to raise up to $60 million. The offering will ...
HAYWARD, Calif. - Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company, has announced a rights offering for its common stockholders, aiming to raise up to $60 million. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results